SPARC is a key mediator of TGF‐β‐induced renal cancer metastasis-Reference-Cited by-同舟云学术

SPARC is a key mediator of TGF‐β‐induced renal cancer metastasis

Published:2020-08-11 Issue:3 Volume:236 Page:1926-1938
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Bao Ji‐Ming¹²,Dang Qiang¹,Lin Chun‐Jung²,Lo U‐Ging²,Feldkoren Boris²,Dang Andrew²,Hernandez Elizabeth²,Li Fei¹,Panwar Vandana³,Lee Cheng‐Fan²,Cen Jun‐Jie⁴,Guan Bing²,Margulis Vitaly²,Kapur Payal³,Brekken Rolf A.⁵,Luo Jun‐Hang⁴,Hsieh Jer‐Tsong²^ORCID,Tan Wan‐Long¹

Affiliation:

1. Department of Urology, Nanfang Hospital Southern Medical University Guangzhou China

2. Department of Urology University of Texas Southwestern Medical Center Dallas Texas

3. Department of Pathology University of Texas Southwestern Medical Center Dallas Texas

4. Department of Urology, The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

5. Division of Surgical Oncology, Department of Surgery and Pharmacology, Hamon Center for Therapeutic Oncology Research University of Texas Southwestern Medical Center Dallas Texas

Funder

American Cancer Society

China Scholarship Council

Institut National Du Cancer

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29975

Reference47 articles.

1. Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation